.jpg)
STAT+: ‘It’s going to set the bar pretty high’: A path forward for trusted AI in breast cancer risk prediction
As the role of artificial intelligence grows in medicine, one of the leading concerns is…
Author: STAT
Watch: A conversation with the 2021 STAT Wunderkinds
Each year, STAT sets out to celebrate the unheralded heroes of science and medicine, poring…
STAT+: How America’s largest Catholic hospital system is moonlighting as a private equity firm
The nation’s largest Catholic hospital system, a sprawling behemoth of more than 140 hospitals called…
STAT+: In a sudden move, Al Sandrock, the man behind Biogen’s Aduhelm, to retire
Al Sandrock, Biogen’s top scientist and the face of its years-long campaign to develop a…
Opinion: Texting saved lives during Covid. What does that mean for health care’s future?
Despite the ongoing push to increase the number of vaccinated people in the U.S., about…
Scientists report finding a second person to be ‘naturally’ cured of HIV, raising hopes for future treatments
One evening in March 2020, a doctor walked out of a hospital in the Argentine…
STAT+: Conflicts of interest exist among editors and authors of widely used psychopharmacology textbooks
Amid ongoing concerns over conflicts of interest that may affect medical practice, a new analysis…
STAT+: Biogen’s pricey Alzheimer’s drug will fuel record premium hikes for Medicare Part B
The high cost of the Alzheimer’s drug from Biogen (BIIB) is a key reason that…
STAT+: Pharmalittle: Califf has lots of unfinished FDA business; FDA’s warnings prompt trial sponsors to report results
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: It’s time for individuals — not doctors or companies — to own their health data
Health data should be like a mountain stream, flowing in a single direction with a…
Opinion: Why two emergency physicians’ kids took part in the Pfizer vaccine trials
Cue the collective sigh of relief from many parents across the country. While the Pfizer-BioNTech…
8 lingering questions about the new Covid pills from Merck and Pfizer
The past two months have brought extremely good news in the fight against Covid-19. Two…
STAT+: When FDA rattles its sabre, drug makers and universities start reporting overdue trial results
Over the past eight years, more than 90% of drug makers and universities that received…
Biden taps Califf to helm FDA — an agency where he has plenty of unfinished business
WASHINGTON — Robert Califf, President Biden’s new pick to lead the Food and Drug Administration,…
STAT+: Pharmalittle: J&J to split into two companies; AstraZeneca will price its Covid-19 vaccine to make it profitable
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Broadband access: Health care’s newest challenge
The past two years have underscored the long-standing but always disturbing reality that millions of…
.jpg)
Opinion: Isolated in Uganda: How Covid-19 evacuations highlight unfairness of global health partnerships
Patients gasping for air in hospital hallways, trailers serving as makeshift morgues, emergency medical tents…
STAT+: 5 health tech startups targeting the Medicaid population to watch
When it comes to new opportunities, health tech companies tend to follow the money. That…
STAT+: Startup Spotlight: Rectify is hoping it can mend broken ABC transporters, starting in the liver
A former Vertex scientist is setting his sights on an entire family of transporter proteins…
STAT+: ‘A work in progress’: BioNTech’s CEO wants to widen Covid-19 vaccine access on his own terms
Two years ago, Ugur Sahin was an under-the-radar but extremely determined scientist running a company…
Listen: Moderna v. NIH, psilocybin as a medicine, & the cultural intake of pharma CEOs
Who invented Moderna’s Covid-19 vaccine? Can psychedelic medicines be mainstream? And who’s going to run…
STAT+: Cortexyme bets a lower dose of its once-failed Alzheimer’s drug can work in another trial
Cortexyme, pressing forward after its novel approach to Alzheimer’s disease failed in a mid-stage trial,…
Using optogenetics, scientists pinpoint the location and timing of memory formation in mice
A mouse finds itself in a box it’s seen before; inside, its white walls are…
STAT+: Pharmalittle: NIH to fight Moderna in court over Covid-19 vaccine patents; ‘puzzling’ results in an Alzheimer’s study
Rise and shine, another busy day is on the way. We can tell because our…
5 years of progress: The first STAT Wunderkinds on their biggest challenges and proudest moments in science
Next week, STAT will unveil its fifth class of Wunderkinds, a group of doctors and…
‘You need a whole team’: How a virtual mentoring program has helped bring care closer to rural patients
By the time Sanjeev Arora’s patient had trekked the 200 miles to his office to…
Sequencing whole genomes helps diagnose far more rare diseases, study shows
When the U.K.’s National Health Service started to use whole genome sequencing, doctors were able…
STAT+: ‘Quite puzzling’ results in Alzheimer’s study cloud future of tau-targeting antibody treatment
New clinical trial results may temper early hope for an experimental Genentech treatment that targets…
Opinion: Understanding health care consumer preferences is key to effective Covid-19 vaccination messaging
Health care, like politics, is local. The performance of certain procedures or the prevalence of…
STAT+: Pharmalittle: Moderna and NIH clash over Covid-19 vaccine patent; Biogen probes Alzheimer’s patient death
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Company that sold overdose antidote to pay $12.7 million to settle charges of fraudulent scheme
Kaleo, a small and controversial company, agreed to pay $12.7 million to resolve allegations that…
Opinion: Listen: A patient and a nephrologist on how using race in kidney testing puts lives at risk
Ever since medicine adopted a race-based formula to assess kidney health in the mid-2000s, some…
STAT+: Obesity journal editor’s extensive company ties raise concerns about conflicts of interest in publishing
Over the past seven years, a top editor at a medical journal devoted to obesity…
What would the public health experts do? STAT asked 28 about their holiday plans amid Covid-19
It has been nearly two years since Covid-19 reared its ugly head, as best we…
Opinion: I’m almost always the only Hmong American scientist in the room. Yet I was told I come from a group overrepresented in STEM
I grew up in a small, low-income community surrounded by diverse groups of people, including…
STAT+: Oklahoma court overturns $465 million opioid verdict against Johnson & Johnson
The Oklahoma Supreme Court overturned a $465 million judgment against Johnson & Johnson (JNJ) in…
STAT+: Anti-aging research foundation stands by ouster of Aubrey de Grey after investigation concludes
Aubrey de Grey, the anti-aging research pioneer who was removed in August as chief scientific…
Largest psilocybin trial finds the psychedelic is effective in treating serious depression
Eagerly awaited results of the largest-ever study of psilocybin were announced Tuesday, with Compass Pathways…
Opinion: Drug pricing bill’s unintended consequences will distort drug development
After months of wrangling, Democratic lawmakers have agreed on a drug pricing bill. The House…
STAT+: STAT+ Conversation: Drug pricing drama
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Pelosi was the real holdout in drug-pricing talks; U.S. to pay $1 billion for more Merck Covid pills
Hello, everyone, and how are you this morning? Despite some tech challenges today, we are…
Opinion: Preventing market failure in brain health: Moving toward fixes in investment, operations, and governance
The world is in the midst an escalating global crisis of brain health, by which…
The U.K. is on its way to eliminating cervical cancer. Here’s why the U.S. isn’t close
A decade ago, a London cancer prevention researcher predicted that the United Kingdom’s national HPV…
How Nancy Pelosi almost killed drug pricing reform
WASHINGTON — The White House stunned health care experts last month when it declared it was…
STAT+: Can David Feinberg fix Cerner? The new CEO of an electronic health record giant faces fresh threats
In many ways, David Feinberg was an unconventional choice to lead Cerner, one of the…
STAT+: A controversial drug for premature births, which FDA wants withdrawn, is tied to elevated cancer risk
The key ingredient in a controversial medicine used to prevent premature births is associated with a…
STAT+: Hospitals charge insurers and cash-paying patients much more than what Medicare pays for some infused drugs
Nearly a dozen of the highest-rated hospitals in the U.S. charged commercial health insurers and…
STAT+: More lung cancer patients see tumor responses with Mirati’s KRAS combination treatment
Mirati Therapeutics said Monday that more than 60% of patients with lung cancer showed confirmed…
STAT+: Pharmalittle: Court rulings on 340B drug discounts conflict; Swiss socialists want government to buy Sandoz
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Q&A: Bioethicist Leigh Turner on the worrisome boom in unregulated stem cell clinics
In 2016, the Food and Drug Administration put the emerging stem cell cottage industry on…